Teva’s UK subsidiary has joined forces with techbio company Closed Loop Medicine to use its software as a medical device (SaMD) technology platform in the development of new personalised medicines.
Details of the alliance are sparse at the moment, but the two companies have revealed that they are looking at ways to improve drug efficacy and outcomes in patients with specific chronic disorders by combining dose-optimised drug therapy with digital care.
Details of the alliance are sparse at the moment, but the two companies have revealed that they are looking at ways to improve drug efficacy and outcomes in patients with specific chronic disorders by combining dose-optimised drug therapy with digital care.
